This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
News watchers around the U.S. have likely seen the warnings: without certificate of need (CON) laws, hospitals will be forced to close their doors when for-profit organizations open and cherry pick commercially insured patients, leaving those in rural areas without care. The reality is that even with certificate of need laws in place, rural patients are already without care.
The federal government is rescoring the quality ratings of this year’s Medicare Advantage plans, which could lead to an additional $1 billion of taxpayer money flowing into the coffers of health insurance companies. Recent court decisions required the Biden administration to make these changes to insurers’ star ratings, many of which came in lower than companies had expected and cost them hundreds of millions of dollars in bonuses.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting the value communities place on them, every state and the District of Columbia require children to get vaccinated against certain diseases before they start school, including measles, mumps, polio, tetanus, whooping cough, and chickenpox. Troubling stories about outbreaks of previously eradicated diseases like measles notwithstanding, most schools are free of vaccine-preventable diseases.
WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, the Senate health committee announced Friday. The agreement is a finale to a farcical public back-and-forth over apparent difficulties between the Senate health committee and Novo in scheduling a hearing.
Large multiple pharmacies have delivered around 200,000 Pharmacy First consultations in under six months. Since 31 January, Company Chemists’ Association (CCA) member pharmacies have delivered 209,200 Pharmacy First consultations, the CCA said on Wednesday. CCA chief executive Malcolm Harrison said the strong patient interest demonstrated ‘that the service is here to stay’.
LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide footprint to recruit customers who pick up drugs at its stores into clinical trials , in an effort to diversify participation in studies of new medicines. Other retailers have struggled with similar efforts to expand beyond their core pharmacy operations. Last year, CVS ended its clinical trial endeavors after two years, and earlier this year, Walmart closed several of its medical clinics.
Stay up-to-date with the latest news in clinical trials with highlights from NMD Pharma, Minoryx Therapeutics, Moonlake Immunotherapeutics, and Ipsen. Discover the groundbreaking developments from 10th to 14th June.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the injectable treatment is “unaffordable” for patients. The Colorado Prescription Drug Affordability Board voted Friday to grant the designation to Cosentyx, which is used to treat conditions such as plaque psoriasis and psoriatic arthritis.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Lupin announced that the United States Food and Drug Administration has completed an inspection of its injectable facility in Nagpur, India. The inspection of the facility was carried out from June 10 to June 13, 2024 , and concluded with zero 483 observations. Nilesh Gupta, Managing Director, Lupin said, “We are pleased to have a successful outcome of the U.S.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. This shining star does however have two chinks in the armour that industry leaders will be well served to address.
The national medical director at NHS England has expressed alarm at reports of weight loss medication being used inappropriately. Speaking at the NHS Confed Expo conference in Manchester this week, Professor Stephen Powis said that new weight loss drugs were going to be an ‘important part’ of the NHS’s approach to tackling obesity. But he […] The post NHSE medical director 'alarmed' by reports of inappropriate weight loss drug use appeared first on The Pharmacist.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
SKAN Research Trust, promoted by Indian entrepreneur Ashok Soota, and UK-based Quadram Institute Bioscience announced that they will apply the TraDIS-Xpress platform to study the action of traditional medical compounds on bacteria, thereby aiding in the reformulation and development of novel antibacterial regimens. TraDIS-Xpress is Quadram’s proprietary genetic sequencing platform that is working to uncover new antimicrobial agents and develop better prebiotics and probiotics for health promotio
Sun Pharmaceutical Industries, (including its subsidiaries or associate companies) and Israel-based Moebius Medical presented data demonstrating the durability of pain relief achieved in symptomatic knee OA patients through 26 weeks post-injection of MM-II. The results, presented at EULAR 2024, are based on an analysis from the randomised, controlled, Phase 2b clinical study (NCT04506463).
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have made a license agreement, whereby AbbVie will develop, manufacture and commercialise a next generation TL1A antibody for inflammatory bowel disease (IBD). FG-M701 is a fully human monoclonal antibody targeting TL1A. This target plays a role in inflammatory autoimmune diseases. While AbbVie is set to advance the monoclonal antibody through development and beyond, the treatment is currently in preclinical development.
Pharmacies have been advised they should order alternative vaccines from an approved list, after Sanofi has said its recombinant quadrivalent influenza vaccine (QIVr) would not be available for this year’s flu programme. In addition, the start date for the 2024/25 adult flu vaccination campaign has been confirmed as 3 October, NHS England announced in this […] The post Adult flu campaign to start 3 October but QIVr vaccine unavailable appeared first on The Pharmacist.
Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered. Obesity increases the frequency of macrophages in tumors and induces their expression of the immune checkpoint protein PD-1 - a target of cancer immunotherapies.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content